Literature DB >> 6193958

Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies.

J L Millán, T Stigbrand.   

Abstract

Placental alkaline phosphatase (PLAP) in humans shows a high degree of genetic polymorphism as disclosed by electrophoretic analysis. Human testes contain trace amounts of a PLAP-like enzyme, that although immunologically cross-reactive with PLAP, shows unique catalytic properties. As an alternative approach to study enzyme polymorphism we have developed monoclonal antibodies to purified allelic variants of PLAP. Five different monoclonal antibodies are described in this report. The antibodies react with different epitopes on the PLAP molecule. Both conformational dependent and independent determinants are detected. Two epitopes are modified when comparing the S and F allelic variants of PLAP. One epitope is common to PLAP and the intestinal isoenzyme of alkaline phosphatase. The five epitopes appear to be mapped on two rather distant antigenic domains. Combinations of any two antibodies binding to different domains give immunoprecipitates with PLAP on Ouchterlony tests and give good response in sandwich enzyme-linked immunosorbent assays. A study of PLAP-like enzyme in 32 individual testis samples indicates differences in four of the epitopes when compared with PLAP. Four types of testicular enzymes can be distinguished based on their reactivities. These results indicate structural differences between the testicular PLAP-like enzyme and PLAP. These differences are compatible with an underlying genetic mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193958     DOI: 10.1111/j.1432-1033.1983.tb07697.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  [Isoenzymes].

Authors:  G Pfleiderer
Journal:  Naturwissenschaften       Date:  1986-11

2.  Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.

Authors:  H Yamamoto; U Rudén; P Esposti; K Hirano; T Stigbrand; L Andersson; H Hisazumi; B Wahren
Journal:  Urol Res       Date:  1988

3.  Expression of different-sized placental alkaline phosphatase mRNAs in placenta and choriocarcinoma cells.

Authors:  C E Ovitt; A W Strauss; D H Alpers; J Y Chou; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Analysis of serum placental alkaline phosphatase activity in testicular cancer and cigarette smokers.

Authors:  K Koshida; T Stigbrand; E Munck-Wikland; H Hisazumi; B Wahren
Journal:  Urol Res       Date:  1990

5.  Purification and properties of Myxococcus xanthus cell surface antigen 1604.

Authors:  B W Jarvis; M Dworkin
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

6.  Gly429 is the major determinant of uncompetitive inhibition of human germ cell alkaline phosphatase by L-leucine.

Authors:  C Hummer; J L Millán
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

7.  Molecular mechanism of uncompetitive inhibition of human placental and germ-cell alkaline phosphatase.

Authors:  M F Hoylaerts; T Manes; J L Millán
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

8.  Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.

Authors:  David Eriksson; Homa Mirzaie Joniani; Ali Sheikholvaezin; Per-Olov Löfroth; Lennart Johansson; Katrine Riklund Ahlström; Torgny Stigbrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-30       Impact factor: 9.236

9.  Human placental and intestinal alkaline phosphatase genes map to 2q34-q37.

Authors:  C A Griffin; M Smith; P S Henthorn; H Harris; M J Weiss; M Raducha; B S Emanuel
Journal:  Am J Hum Genet       Date:  1987-12       Impact factor: 11.025

10.  Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylation.

Authors:  R Chen; E I Walter; G Parker; J P Lapurga; J L Millan; Y Ikehara; S Udenfriend; M E Medof
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.